Players' associations urge Congress to reject proposed bill granting NCAA antitrust exemption
The statement was in response to the Student Compensation and Opportunity through Rights and Endorsements (SCORE) Act, introduced last week by members of the House Energy and Commerce Committee. A markup on the bill is scheduled for Tuesday morning.
Advertisement
In their letter, the players' associations warned that an antitrust exemption would permit the NCAA and its members to 'collude to harm athletes.'
'Whatever progress the athletes have made has been a result of their use of the antitrust laws,' they wrote. 'The SCORE Act would take that weapon away from them.'
The proposed legislation from seven Republican and two Democratic sponsors prevents athletes from obtaining employment status and mirrors many of the terms from the recent House vs. NCAA settlement. It would officially end most administrative restrictions on athletes' NIL compensation, but it allows schools and conferences to establish what is and isn't permissible. Should the federal legislation pass, it would override current state NIL laws, which vary from state to state.
Earlier Monday, two members of Congress from the state of Washington, Democratic Sen. Maria Cantwell (D-WA), Ranking Member of the Senate Committee on Commerce, Science and Transportation, and Republican Rep. Michael Baumgartner, issued a similar statement urging the House committee to delay the markup until there are significant changes.
Advertisement
'The bill appears to be a product of the richest conferences to cement into place the current power structure in college athletics that would leave only the wealthiest schools able to compete at the highest levels of college athletics,' the statement said.
All of the Power 5 conferences previously issued a statement endorsing the SCORE Act.
'In the absence of federal standards, student-athletes and schools have been forced to navigate a fractured regulatory framework for too long,' they wrote. 'Following the historic House settlement, this bill represents a very encouraging step toward delivering the national clarity and accountability that college athletics desperately needs.'
Advertisement
Last week, the NCAA said in a statement that it 'has made long overdue changes, mandating health and wellness benefits and ushering in a new system for Division I programs to provide up to 50 percent of athletic department revenue to student-athletes, but some of the most important changes can only come from Congress.'
'This bill reflects many student-athletes' priorities, and the NCAA is committed to working with Congress to build a bipartisan path forward that ensures the long-term success of college sports and the ongoing opportunities they provide to young people,' wrote Tim Buckley, the NCAA's senior vice president of external affairs.
SEC commissioner Greg Sankey also praised the bill Monday.
'I think what's happening in college athletics is a nonpartisan issue, but using the typical nomenclature, to have members of both of our major political parties willing to step out and introduce the SCORE Act, is a positive step,' he said.
The players' associations' letter noted that only two industries in the United States have antitrust law exemptions: railroads and Major League Baseball (partially).
Advertisement
'The NCAA should not have a blank check to impose (its) will on the financial future of over 500,000 college athletes,' they wrote.
This article originally appeared in The Athletic.
College Football, Men's College Basketball, Women's College Basketball, College Sports
2025 The Athletic Media Company
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
18 minutes ago
- Associated Press
US appeals court upholds West Virginia restriction on abortion pill sales
CHARLESTON, (AP) — A federal appeals court on Tuesday upheld a lower court's decision to restrict abortion pill sales in West Virginia. A three-judge panel of the 4th U.S. Circuit Court of Appeals in Richmond, Virginia, affirmed a ruling by a U.S. district judge in 2023 despite federal regulators' approval of the abortion pill as a safe and effective medication. Most Republican-controlled states have enacted or adopted abortion bans of some kind, including restricting abortion pills by default, since the U.S. Supreme Court in 2022 overturned Roe v. Wade, the 1973 ruling that provided nationwide access to abortion. All have been challenged in court. The Supreme Court ruled in the case of Dobbs v. Jackson Women's Health Organization. U.S. District Court Judge Robert C. Chambers had ruled that the near-total abortion ban signed by then-Republican Gov. Jim Justice in September 2022 took precedence over approvals from the U.S. Food and Drug Administration. 'For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would leave us one small step short of defiance,' 4th Circuit Judge J. Harvie Wilkinson III wrote for the court. 'One can of course agree or disagree with the Dobbs decision. But that is not the point,' Wilkinson said. 'At a time when the rule of law is under blunt assault, disregarding the Supreme Court is not an option.' West Virginia Gov. Patrick Morrisey, who took office in January, had defended challenges to the abortion law when he served as attorney general. 'Big win out of the 4th Circuit today,' Morrisey said in a statement. GenBioPro Inc., the country's only manufacturer of a generic version of the abortion pill mifepristone, had argued that the state cannot block access to a FDA-approved drug. Chambers had dismissed the majority of GenBioPro's challenges, finding there is 'no disputing that health, medicine, and medical licensure are traditional areas of state authority.' Appeals judge DeAndrea Gist Benjamin concurred and dissented in part Tuesday, calling it a 'troubling opinion.' 'Put plainly, this law erects barriers to life-saving healthcare for countless West Virginians in ways not envisioned by Congress,' Benjamin wrote. Not at issue in the appeal was a challenge by GenBioPro concerning a separate West Virginia law that stopped providers from prescribing mifepristone by telehealth. Chambers had allowed that challenge to proceed. The U.S. Supreme Court last year unanimously preserved access to mifepristone, which is used in nearly two-thirds of all abortions in the U.S. in 2023.
Yahoo
18 minutes ago
- Yahoo
The Ethically Dubious Soup Kim Jong-Un Loves To Dine On Is Illegal In The US
Among the many notorious and weird facts about North Korean dictator Kim Jong-Un is his taste for extravagance and taboo delicacies. One of the most controversial dishes he's reportedly fond of is shark fin soup, a once-celebrated luxury in some East Asian cultures that has become a global symbol of animal abuse and environmental destruction. In 2022, after years of pressure by animal welfare and ocean nonprofits, Congress passed the Shark Fin Sales Elimination Act of 2021, making it illegal to possess or sell shark fins in the United States due to the brutal methods used to harvest the fins and the devastating consequences for marine ecosystems. Shark fin soup has a long history in Chinese imperial cuisine, where it symbolized wealth, power, and prestige. The soup is made using the fins of sharks, which are prized for their texture rather than their flavor. To meet the demand for this status symbol, the inhumane practice of "finning" became widespread: Sharks are caught, their fins sliced off while they're still alive, and their mutilated bodies are often thrown back into the ocean. Shark meat itself is also unsustainable, but receives less attention, unless it's the Icelandic fermented shark that Anthony Bourdain refused to eat ever again. Some shark species have seen population drops of more than 90% in recent decades. Conservationists warn that removing apex predators like sharks from the oceans will destabilize entire ecosystems, yet the demand for shark fin soup continues in some parts of the world, fueled by tradition and status. Read more: 10 Cheap Fish That Are Absolutely Not Worth Buying Kim Jong-Un's love of shark fin soup is emblematic of the North Korean regime's tendency to flaunt excess, even as most of the country suffers from devastating food insecurity and economic hardship. According to reports from defectors and international observers, the North Korean elite enjoys access to expensive delicacies like Kobe steaks, caviar, and champagne . Serving shark fin soup at state banquets or private gatherings isn't just about taste — it's Jong-Un's way to signal dominance and privilege. Kenji Fujimoto, a Japanese sushi chef who served the Kim family for over a decade, described making the soup for the political family after he defected to Japan in 2001. In an interview with Japanese media, he stated, "They both like shark fin soup three times a week." Fujimoto's stories don't stop there; he describes flying to Iran to pick up caviar, Denmark for beer, and Japan for fish. Nothing was too good for the family of Korean dictators. Many American chefs and restaurants have voluntarily removed shark fin soup from their menus in response to legal pressure and growing public awareness of its cruelty. Chef Gordon Ramsey avoids the soup at all costs after starring in an investigative documentary about the brutal practice. In a country where food is weaponized and extreme poverty is widespread for everyday people, the presence of a controversial luxury dish like shark fin soup reveals a lot about Jong-Un's values and power plays in Pyongyang. For more food and drink goodness, join The Takeout's newsletter. Get taste tests, food & drink news, deals from your favorite chains, recipes, cooking tips, and more! Read the original article on The Takeout.
Yahoo
20 minutes ago
- Yahoo
Here's Why Ducommun (DCO) is a Great Momentum Stock to Buy
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at Ducommun (DCO), a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score. It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Ducommun currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period. You can see the current list of Zacks #1 Rank Stocks here >>> In order to see if DCO is a promising momentum pick, let's examine some Momentum Style elements to see if this aerospace industry supplier holds up. Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area. For DCO, shares are up 0.94% over the past week while the Zacks Aerospace - Defense Equipment industry is up 0.15% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 13.92% compares favorably with the industry's 7.41% performance as well. Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Ducommun have increased 60.02% over the past quarter, and have gained 46.68% in the last year. On the other hand, the S&P 500 has only moved 16.27% and 12.91%, respectively. Investors should also pay attention to DCO's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. DCO is currently averaging 153,468 shares for the last 20 days. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with DCO. Over the past two months, 1 earnings estimate moved higher compared to none lower for the full year. This revision helped boost DCO's consensus estimate, increasing from $3.65 to $3.68 in the past 60 days. Looking at the next fiscal year, 1 estimate has moved upwards while there have been no downward revisions in the same time period. Given these factors, it shouldn't be surprising that DCO is a #1 (Strong Buy) stock and boasts a Momentum Score of A. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Ducommun on your short list. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ducommun Incorporated (DCO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
